Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury

Lynn Boshkov, E. E. Tredget, A. Janowska-Wieczorek

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

We report the use of recombinant human erythropoietin (rh-Ep) as an alternative to transfusion therapy in a burn victim who was a Jehovah's Witness and refused blood transfusion. Despite endogenous elevated erythropoietin levels, the patient was reticulocytopenic and administration of rh-Ep was accompanied by a 10-fold increase in reticulocyte response and a rise in hemoglobin from 7.4 to 10.4 g/dl over a 12-day period. We suggest that the exogenously administered erythropoietin overcame a clinically inadequate endogenous erythropoietin response.

Original languageEnglish (US)
Pages (from-to)53-54
Number of pages2
JournalAmerican Journal of Hematology
Volume37
Issue number1
StatePublished - 1991
Externally publishedYes

Fingerprint

Jehovah's Witnesses
Erythropoietin
Anemia
Hot Temperature
Wounds and Injuries
Reticulocytes
Blood Transfusion
Hemoglobins

Keywords

  • anemia
  • burns
  • recombinant human erythropoietin (rh-Ep)

ASJC Scopus subject areas

  • Hematology

Cite this

Boshkov, L., Tredget, E. E., & Janowska-Wieczorek, A. (1991). Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury. American Journal of Hematology, 37(1), 53-54.

Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury. / Boshkov, Lynn; Tredget, E. E.; Janowska-Wieczorek, A.

In: American Journal of Hematology, Vol. 37, No. 1, 1991, p. 53-54.

Research output: Contribution to journalArticle

Boshkov, L, Tredget, EE & Janowska-Wieczorek, A 1991, 'Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury', American Journal of Hematology, vol. 37, no. 1, pp. 53-54.
Boshkov, Lynn ; Tredget, E. E. ; Janowska-Wieczorek, A. / Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury. In: American Journal of Hematology. 1991 ; Vol. 37, No. 1. pp. 53-54.
@article{92a29eb04b98403fa63aeaa62f051909,
title = "Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury",
abstract = "We report the use of recombinant human erythropoietin (rh-Ep) as an alternative to transfusion therapy in a burn victim who was a Jehovah's Witness and refused blood transfusion. Despite endogenous elevated erythropoietin levels, the patient was reticulocytopenic and administration of rh-Ep was accompanied by a 10-fold increase in reticulocyte response and a rise in hemoglobin from 7.4 to 10.4 g/dl over a 12-day period. We suggest that the exogenously administered erythropoietin overcame a clinically inadequate endogenous erythropoietin response.",
keywords = "anemia, burns, recombinant human erythropoietin (rh-Ep)",
author = "Lynn Boshkov and Tredget, {E. E.} and A. Janowska-Wieczorek",
year = "1991",
language = "English (US)",
volume = "37",
pages = "53--54",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury

AU - Boshkov, Lynn

AU - Tredget, E. E.

AU - Janowska-Wieczorek, A.

PY - 1991

Y1 - 1991

N2 - We report the use of recombinant human erythropoietin (rh-Ep) as an alternative to transfusion therapy in a burn victim who was a Jehovah's Witness and refused blood transfusion. Despite endogenous elevated erythropoietin levels, the patient was reticulocytopenic and administration of rh-Ep was accompanied by a 10-fold increase in reticulocyte response and a rise in hemoglobin from 7.4 to 10.4 g/dl over a 12-day period. We suggest that the exogenously administered erythropoietin overcame a clinically inadequate endogenous erythropoietin response.

AB - We report the use of recombinant human erythropoietin (rh-Ep) as an alternative to transfusion therapy in a burn victim who was a Jehovah's Witness and refused blood transfusion. Despite endogenous elevated erythropoietin levels, the patient was reticulocytopenic and administration of rh-Ep was accompanied by a 10-fold increase in reticulocyte response and a rise in hemoglobin from 7.4 to 10.4 g/dl over a 12-day period. We suggest that the exogenously administered erythropoietin overcame a clinically inadequate endogenous erythropoietin response.

KW - anemia

KW - burns

KW - recombinant human erythropoietin (rh-Ep)

UR - http://www.scopus.com/inward/record.url?scp=0025890331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025890331&partnerID=8YFLogxK

M3 - Article

C2 - 2024641

AN - SCOPUS:0025890331

VL - 37

SP - 53

EP - 54

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 1

ER -